All patients.
- Measure and treat blood pressure on the arm with the higher reading. Avoid blood pressure checks, venous cannulation and arterial lines on the affected side where possible.
- Aspirin 75 to 100 mg orally once daily (usual maximum 325 mg daily), or clopidogrel 75 mg once daily if aspirin is not tolerated, with pantoprazole 40 mg once daily for gastric protection (avoid omeprazole and esomeprazole with clopidogrel).
- Atorvastatin 40 to 80 mg orally once daily with liver enzymes at baseline and 3 months, aiming for LDL cholesterol under 1.4 mmol/L (55 mg/dL). Avoid in pregnancy.
- Blood pressure under 130/80 mm Hg, smoking cessation, glucose control and exercise.
Asymptomatic stenosis. No revascularisation. Surveillance by symptoms and arm pressures.
Indications for revascularisation. Disabling arm claudication, posterior circulation symptoms with steal, angina from coronary subclavian steal, impaired dialysis access, and any stenosis that needs treatment before bypass using an internal mammary artery.
Options.
- Endovascular repair is usual first choice for focal stenosis and short occlusions. Balloon expandable stents suit ostial lesions and self-expanding stents suit non-ostial lesions. Technical success is about 95%, with 5-year primary patency of about 80 to 90%. Risks are stroke (about 1%), embolisation, dissection, vertebral flow disturbance and restenosis in about 10 to 20%.
- Open repair: carotid subclavian bypass, or subclavian carotid transposition, for long or calcified lesions and failed stenting. Patency is over 90% at 10 years, with a stroke rate of about 1%, and risks of phrenic nerve palsy, Horner syndrome and thoracic duct injury.
- After stenting: aspirin 75 to 100 mg plus clopidogrel 75 mg once daily for 1 month, then a single antiplatelet drug long term.
- Treat the stenosis before, or at the same time as, coronary bypass when an internal mammary artery is planned (or use a different conduit).
Arteritis. Prednisolone 0.5 to 1 mg/kg orally once daily (maximum 60 mg) with a taper and a steroid sparing drug chosen with rheumatology, after screening for tuberculosis and hepatitis B. Revascularise only when inflammation has been quiet for 3 to 6 months.
Special groups. Pregnancy: avoid statins and manage blood pressure with labetalol, modified release nifedipine or methyldopa, using the arm with the higher reading. Region: Takayasu arteritis and tuberculosis are important causes in sub-Saharan Africa and Asia in young women.
Monitoring. Arm pressures and symptoms every 3 to 6 months after treatment, duplex at 1, 6 and 12 months and then yearly, and ESR and CRP in arteritis every 4 to 8 weeks during induction.
Referral and escalation. Refer to vascular surgery or a centre with endovascular capability. Urgent for posterior circulation events, angina with an internal mammary graft, or limb threatening arm ischaemia.